Product Information
Name:VPC-13566
Brand:Biosynth
Description:VPC-13566 is a novel drug that inhibits the production of an endogenous antigen. It binds to a specific molecule on the surface of prostate cancer cells and blocks the growth of these cells. VPC-13566 has been shown to be safe and effective in animal models, and it has been shown to be orally available with good pharmacokinetic properties. This drug is currently in clinical trials for prostate cancer treatment, but it may have potential for other types of cancer as well.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:258.3 g/mol
Formula:C18H14N2
Purity:Min. 95%
Technical inquiry about: VPC-13566
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.